Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine treatment effects in thyroid hormone receptor alpha 1 deficiency
NL-OMON42720Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levothyroxine sodium in resistance to thyroid hormone alpha (RTHα) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Neutrophil and macrophage function prior to and following levothyroxine treatment, Erythropoiesis function and 2 more. Started May 2015; status: active, not recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
resistance to thyroid hormone alpha (RTHα)
Beyond the preview
Go deeper on NL-OMON42720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42720.